乳果糖口服液预防急性心肌梗死患者便秘的疗效观察  

Clinical observation of lactulose oral solution on prevention of constipation in patients with acute myocardial infarction

作　　者：刘璞娉[1] 周美英 艾文[1] 赵越[1] 皮花 

机构地区：[1]深圳市南山区人民医院心内科,广东深圳518052 [2]深圳市南山区妇幼保健医院,广东深圳518052

出　　处：《中国当代医药》2012年第24期73-73,75,共2页China Modern Medicine

摘　　要：目的探讨乳果糖口服液对急性心肌梗死患者卧床期发生便秘的预防效果。方法将90例急性心肌梗死患者随机分为两组,各45例,对照组给予常规护理;实验组在常规护理基础上,加用乳果糖口服液15mL每天2次,口服。结果实验组患者便秘的发生率为6.67%,对照组为35.56%,两组对比,差异有统计学意义(P<0.05)。结论乳果糖口服液对急性心肌梗死患者的便秘有较好的预防作用,且使用方便,不良反应少,患者和家属容易接受。Objective To investigate the effect of lactulose oral solution in preventing from astriction in acute myocardial infarction patients.Methods Ninety patients of acute myocardial infarction were divided equally into two groups,control guop was nursed as regular,therapy group added lactulos 15 mL,twice a day.Results The incidence rate of astriction of therapy group was more significantly reduced than control group（P0.05）.Conclusion Lactulose oral solution can preventing from astriction in acute myocardial infarction patients,it is convenient and acceptable.

关 键 词：乳果糖口服液 急性心肌梗死 便秘 疗效观察 

分 类 号：R972[医药卫生—药品]